Healthcare equity research
Turning biomedical signal into investable insight.
We analyze the market impact of scientific and clinical breakthroughs in the pharmaceutical and healthcare sectors — rigorous models, explicit assumptions, live data.
Market at a glance
$9.8T
Global health spending (2022)
Source · World Bank · WHO
$96B
PhRMA member R&D investment (2023)
Source · PhRMA
$2.6B
Average cost to develop a new drug (2016)
Source · Tufts CSDD